Novo Nordisk - ADR

NYSE:NVO

152.75

+4.36 (+2.94%)

7:59:59 PM EDT: $154.35 +1.60 (+1.05%)

Market Cap (Intraday)	263.68B
Current PE	4.75
Forward PE	33.28
2yr Forward PE	29.21

See more stats

Estimates Current Quarter

Revenue	$7.04 Billion
Adjusted EPS	$1.10

See more estimates

10-Day MA	$145.98
50-Day MA	$141.13
200-Day MA	$119.92

See more pivots

Novo Nordisk - ADR Stock, NYSE:NVO

Novo All�?©, Novo All�?© 1, Bagsv�?�?rd, Capital Region 2880

Denmark

Phone: +45.44.44.88.88

Number of Employees: 54393

http://www.novonordisk.com

Description

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsv�?�?rd, Denmark.